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E D I T O R I A L
The Open Brain Consent: Informing research participants and
obtaining consent to share brain imaging data
Abstract
Having the means to share research data openly is essen-
tial to modern science. For human research, a key aspect in
this endeavor is obtaining consent from participants, not
just to take part in a study, which is a basic ethical princi-
ple, but also to share their data with the scientific commu-
nity. To ensure that the participants' privacy is respected,
national and/or supranational regulations and laws are in
place. It is, however, not always clear to researchers what
the implications of those are, nor how to comply with
them. The Open Brain Consent (https://open-brain-
consent.readthedocs.io) is an international initiative that
aims to provide researchers in the brain imaging commu-
nity with information about data sharing options and tools.
We present here a short history of this project and its lat-
est developments, and share pointers to consent forms,
including a template consent form that is compliant with
the EU general data protection regulation. We also share
pointers to an associated data user agreement that is not
only useful in the EU context, but also for any researchers
dealing with personal (clinical) data elsewhere.
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1 | GOAL AND BACKGROUND
Petabytes of brain imaging data are collected for research purposes
every year, yet only a small fraction becomes publicly available despite
evidence for the benefits of sharing such data sets (Milham
et al., 2018). One reason, among others, is that openly sharing human
brain imaging data requires conforming to established ethical and legal
norms, in particular with respect to ensuring that research partici-
pants' privacy is respected. Ethical and legal requirements are usually
validated by institutional review boards (also known as research ethics
committees), which operate under national, federal, and/or supra-
national regulations. In the case of brain imaging, ethical and legal
norms generally follow international recommendations for medical
research involving human participants, in particular those from the
World Medical Association: the declaration of Helsinki (World Medical
Association, 2001) which lays down ethical principles for medical
research involving human subjects, and the declaration of Taipei
(World Medical Association, 2017) which lays down ethical principles
regarding health databases and biobanks.
In some scientific disciplines, for example, genetics (Khan, Capps,
Sum, Kuswanto, & Sim, 2014), consent is widely discussed and ana-
lyzed, and templates for participant consent forms are available and
commonly used, for example, for clinical trials (https://www.who.int/
ethics/review-committee/informed_consent/en/). To date, similar
work has not been undertaken for brain imaging studies. The goal of
the Open Brain Consent initiative is to facilitate brain imaging data
sharing by providing practical tools that enable data sharing while
respecting research participants' privacy. It consists primarily in pro-
viding widely acceptable information/consent forms allowing
processing and deposition of data into appropriate archives for future
(re)use. Additionally, the project website references tools/pipelines to
minimize the risk of re-identification and provides additional informa-
tion about the various regulations to help brain imaging researchers.
2 | PROJECT HISTORY AND
CONTRIBUTION MODEL
The Open Brain Consent project was started in 2014 to provide (a) a
collection of existing samples of consent forms allowing data sharing,
(b) a reference “ultimate” consent form, and (c) tools helpful for
pseudonymization, making brain imaging data easier to share. The goal
of having a template consent form was, and still is, to establish a rec-
ommended wording for a consent form based on collected examples
that represent community wide expertise. At that time, the OpenfMRI
archive (later developed into OpenNeuro) (Poldrack et al., 2013) was
confronted with issues related to the rights to share the growing
Received: 25 August 2020 Revised: 11 January 2021 Accepted: 12 January 2021
DOI: 10.1002/hbm.25351
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
© 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
Hum Brain Mapp. 2021;1–7. wileyonlinelibrary.com/journal/hbm 1
number of data sets being submitted. To address them, OpenfMRI
established a recommended wording which was contributed to the
Open Brain Consent project in 2015. Since then, many researchers
have joined the project to provide translations to a number of lan-
guages and to expand the list of sample forms and tools. In 2018, the
advent of the European General Data Protection Regulation (GDPR:
https://gdpr-info.eu) left many researchers unsure about the sharing
of brain imaging data, since anonymous data can be shared freely, but
personal data cannot. An online discussion ensued concerning the sta-
tus of brain imaging data, and work began to revise the “Ultimate”
Open Brain Consent form to make sharing brain imaging data, GDPR
compliant. This work took place in particular during the Organization
for Human Brain Mapping (https://www.humanbrainmapping.org)
“hackathon” in Rome (June 2019). Based on this work, the most
recent rewriting took place in November 2019 (and the following
weeks) during a GLiMR action workshop (https://glimr.eu) hosted at
the COST association (https://www.cost.eu) in Brussels.
The Open Brain Consent project is hosted on GitHub (https://
github.com/con/open-brain-consent). Contributions to the project are
submitted via GitHub's Pull Request mechanism for changes to the
text and recommended additions to sample forms or detected issues
are proposed via Issues. The project is open access, all materials are
provided under CC-BY-SA 3.0 license, and we encourage researchers
across the world to contribute their knowledge about data privacy,
(personal) information protection, data sharing and consent. The full
history of changes to the project is available in its Git history, and cit-
able releases are provided through Zenodo.org (Halchenko
et al., 2019).
3 | ETHICAL CONCERNS WHEN SHARING
BIOMEDICAL AND BRAIN IMAGING DATA
As more brain imaging data and biomedical data are shared openly,
concerns have been raised in several publications about risks to data
privacy. From a legal and ethical standpoint, risks about research par-
ticipants' privacy must be identified and mitigated. This necessitates,
on one hand, that procedures for data de-identification are in place
(from pseudonymization to full anonymization) along with means for
individuals to exercise control over the use of their personal data. On
the other hand, it requires retaining as much as possible information
in the data, allowing researchers to use the data to answer specific
research questions. Thus, a balance needs to be struck and that bal-
ance is influenced, in part, by the risks of re-identification based on
current technological possibilities and limitations. For instance, it has
been shown that it is possible to identify participants in the 1,000
Genomes Project by combining publicly available demographic infor-
mation from the American census and public information from the
peoplefinder.com website with anonymized genomic data sets
(Gymrek, McGuire, Golan, Halperin, & Erlich, 2013). This work, how-
ever, relied on having been given secured access to the genomic data
and being able to code and use advanced cryptographic algorithms;
hence, it can be argued that the risk of identification remains low. By
contrast, Rocher, Hendrickx, and de Montjoye (2019) (Rocher
et al., 2019) estimated the likelihood of re-identification of individuals
at around 95% by combining biomedical data and information from
postcodes and census using relatively simple statistical models avail-
able in open source packages like R or Python. The cost and know-
how, in that case, is low and the risk of re-identification is thus higher.
Brain imaging data are often collected along with a range of asso-
ciated biomedical and/or clinical data which represent additional iden-
tifying features. Even if additional biomedical data are not provided,
there are brain imaging specific concerns, especially for magnetic res-
onance imaging (MRI) data. From a standard anatomical MRI of the
participants' head, the facial features can be reconstructed in 3D and
matched to publicly accessible photos. Various approaches have been
proposed to “deface” MRI data, from blurring to zeroing (some e.g., of
defacing algorithms are presented in Figure 1). Such approaches cause
data loss and, if performed too coarsely, can affect the outcome of
analysis pipelines (de Sitter et al., 2020). In addition, recent advances
in machine learning have cast doubt on the efficacy of this approach.
Abramian and Eklund (2019) have been able to “reface” single slice
data with relative success (60 to 75% success) using machine learn-
ing (employing a Generative Adversarial Network), and it is reasonable
to anticipate that methods like these will improve and become more
widely available in the future. Beyond re-identification using direct
identifiers, GDPR highlights that singling out is a precondition to iden-
tification, and it should therefore be minimized. Identification can be
straightforward with an anatomical MRI in which the face is available
since faces are likely unique (Sheehan & Nachman, 2014), but
singling-out individuals from defaced data is also possible based on
the gyral patterns that are unique to every individual (Duan
et al., 2020), like fingerprints. From MRI data that do not include facial
information or detailed anatomy, such as functional MRI data, it is still
possible to single out individuals. For example, Ravindra and
Grama (2019) were able to single out participants across multiple data
sets, using task performance and connectivity patterns, with a success
of 90%. Altogether, these results suggest that biomedical data and
brain MRI in particular, are at risk of re-identification—that is, can in
all likelihood not be fully anonymized—and should therefore be con-
sidered as personal data under the GDPR. Acknowledging that risks to
personal data privacy exist for brain imaging data, identifying them
and putting mechanisms in place to mitigate them are therefore
essential, as is informing each participant throughout the process:
these are core steps in the Open Brain Consent working group.
4 | THE ULTIMATE CONSENT FORM
Provided that national regulations allow data sharing in open public
databases, a consent form template for openly sharing brain imaging
data have been established, and is available in seven languages
(Chinese, English, French, German, Italian, Polish, Spanish—https://
open-brain-consent.readthedocs.io/en/stable/ultimate.html). This
template has been established before the GDPR was in place, and is
recommended for researchers outside the EU. It was informed by
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existing consent forms from various institutions and from discussions
with ethicists. As discussed above, it aims to (a) provide privacy-
related information to the participants and (b) secure open data shar-
ing for researchers. It also establishes a difference between the con-
sent to take part in a research study, and the consent for sharing data
for secondary usage, while these can still be combined in a single
information notice.
Another feature on the consent form is that it comes in two
“flavors” with a single versus dual access model. This differentiates
the open and public sharing of all versus some of the data. In the latter
case, researchers can give controlled access to the data not publicly
shared. This is necessary to address privacy issues related to sharing
biomedical metadata which increases risk of re-identification, as dis-
cussed above.
5 | THE OPEN BRAIN CONSENT, GDPR
EDITION
Under the European GDPR, two types of data are defined: anony-
mous and personal data (Mourby et al., 2018), the latter being further
subdivided based on its sensitivity. Personal sensitive data are data
revealing racial or ethnic origin, sexual orientation, political opinions,
religious, or philosophical beliefs, trade union membership, genetic
data, biometric data processed solely to identify a human being, and
health data. In this context, pseudonymization is a procedure to
reduce the risk of identification by removing or replacing individual
identifiers—for example, address, name—while retaining those identi-
fiers separately from the rest of the individual information (i.e., with
restricted access), thus making it difficult but not impossible to retrace
this information to the actual subject. Since pseudonymization does
not entirely delete the link between the information and the individ-
ual, this does not change the status of the data from personal to anon-
ymous according to the GDPR, thus GDPR does not recognize
pseudonymized data as a distinct category. This means that even after
removing direct identifiers such as names, addresses, but also facial
features, MRI data are likely to remain classified as personal data,
since there is still a risk of re-identification. Such a classification in
turn requires compliance with all relevant aspects of GDPR.
The GDPR-compliant template form (https://open-brain-consent.
readthedocs.io/en/stable/gdpr/index.html) was taken from the ulti-
mate Open Brain Consent form and adapted to comply with the
GDPR, using examples from existing privacy statements and partici-
pant information letters encountered by members of our working
group. The key elements are to (a) have a consent form that only deals
with data sharing; (b) inform participants about the data storage, pri-
vacy measures (e.g., pseudonymization procedure) and control over
usage (e.g., withdrawal) and; (c) provide information on how data will
be shared, specifically outside the EU. These key elements must be
included to promote secondary use of the data (Staunton,
Slokenberga, & Mascalzoni, 2019). The main difference with the non-
EU specific consent form is that further information about privacy and
usage control is provided. For researchers from the EU and affiliated
countries, we therefore recommend having, in addition to their study
consent form, a separate data sharing consent form based on this
template.
5.1 | Data user agreement
As part of information on how data will be shared, we recommend
using a data user agreement (DUA) rather than a license, and a tem-
plate DUA is also provided. Both, the consent and the DUA, are avail-
able in 11 languages (Bosnian, Czech, Dutch [NL/BE], English, Finnish,
French, Italian, Norwegian, Greek, Spanish, Turkish—https://open-
brain-consent.readthedocs.io/en/stable/gdpr/data_user_agreement.
html). Since brain imaging data are seen as personal data, they are
protected and sharing cannot be open and public without a legal gro-
und/lawful basis under GDPR, and therefore only one type of access
is proposed. The use of a DUA is recommended to help mitigate risks
to personal data privacy of the research participants, while still
supporting the sharing of said data with the wider research
F IGURE 1 The typical structural MRI of the brain is made up of a series of 2D slices (left) from which it is easy to reconstruct a face.
Pseudonymization procedures (from the middle to right) go from blurring/masking the face to zero-out an entire part of the image, increasing
anonymity but decreasing usage and sometimes damaging the frontal part of the brain. (This image was made from the MRI of one of the authors,
CP, visualized with MRICRoGL, masked using mask_face (https://nrg.wustl.edu/software/face-masking/usage/), mri_deface from the freesurfer
suite (https://surfer.nmr.mgh.harvard.edu/fswiki/mri_deface) and SPM12 (https://www.fil.ion.ucl.ac.uk/spm/software/spm12/) — (https://doi.
org/10.7488/ds/2877) [Color figure can be viewed at wileyonlinelibrary.com]
EDITORIAL 3
community. The proposed DUA explicitly asks the applicant—the
researcher applying to access the participant data—to confirm that
they will refrain from redistributing the data and attempting to re-
identify the participants. It also makes it clear that any applicant who
downloads the data becomes the data controller, a natural or legal
person, who alone or jointly with others, determines the purposes and
means of the further processing of the personal data. This new data
controller is then responsible for the appropriate usage of the copy of
the shared data, and for ensuring that the agreed terms and condi-
tions are applied/taken care of. This new data controller—or
applicant—does not have to be within the EU, but agrees with the
DUA—which refers to the Standard Contract Clauses (https://ec.
europa.eu/info/law/law-topic/data-protection/international-
dimension-data-protection/standard-contractual-clauses-scc_en)
approved by the European Commission for data transfers to data con-
trollers outside the EU, thus complying with the GDPR—by signing
it. Licenses, in contrast, do not impose such restrictions. While a DUA
must be signed, and usage is limited, it still allows for easy access and
broad reuse within the scientific community. Our proposal is for insti-
tutions to have a “click-through” DUA or similarly automated system
rather than having ad hoc decisions on a case by case basis, which
stands against modern open data practices. This would be particularly
important/ethically desirable if researchers who collect data are also
the ones deciding who has access to them (Bishop, 2016). Having said
that, there are also practical and legal reasons for not using automated
systems, for example, how to ensure the identity of a signatory of the
DUA. If the DUA is not correctly signed by a duly identified controller,
then this may render the DUA legally invalid. There are, however, solu-
tions to this as well, for example, using electronic signatures or regis-
tered user accounts.
6 | DISCUSSION
The Open Brain Consent project aims at facilitating human brain imag-
ing data sharing. By sharing these data as openly as possible,
researchers are confronted with ethical and legal issues. While ethical
issues are internationally recognized and discussed, they are legally
translated differently across countries creating confusion. Here we
tried to reconcile these two aspects by offering two generic consent
template forms that should help with the law in most situations.
Recent technological advances, not only in gathering data and
linking databases, but also from statistical modeling and machine
learning, increase the risk of re-identification of pseudonymized data.
As a result, it is essential to provide up-to-date information to
research participants about data privacy (both privacy risks and right
of control) which are included in the consent forms. Within the EU
context, data that were previously thought to be anonymous are now
considered personal. Although pseudonymization of biomedical data
is still necessary and encouraged, it does not change the data status
from personal to anonymous. Thus, compliance with the GDPR is
required and, depending on national regulation, secured access (with
or without a DUA) might be necessary. We provide information/
consent templates and a DUA template for these different cases,
which we believe will improve researchers' likelihood of getting
approval from their institutional review boards/ethics committees to
share brain imaging data on web-serviced data repositories.
More recent data platform technologies rely on distributed data
storage and/or processing models. A data set collected at multiple
sites could be stored and processed at multiple locations, and yet
accessed via a single query given a user is authorized to access the
data (see e.g., http://datalad.org). It remains to be seen how a DUA
could be implemented for such a distributed model. In other cases,
data analysis can be performed (with local or remote execution) using
algorithms implementing federated learning (Sheller et al., 2020) and
differential privacy concepts (redaction threshold, noise addition,
query limitations, Plis et al., 2016). In such scenarios, privacy concerns
are greatly reduced and the consent template should be modified
accordingly, in particular regarding data confidentiality. Finally, other
initiatives rely on local data processing and sharing of aggregate/
derivative data only (Plis et al., 2016; Thompson et al., 2014). If indi-
viduals cannot be singled out in the shared results, a DUA is not nec-
essary since raw/individual data remain with the data processor and
re-identification becomes impossible.
While we believe standardized templates such as these from the
Open Brain Consent working group play an important role in advanc-
ing transparent research practices, they do not provide a complete
solution to the complex challenges involved in sharing research data.
For example, are data from brain imaging techniques other than MRI
also at risk or re-identification? Since many brain imaging data sets
include various demographics, clinical metadata, and perhaps even
multimodal imaging data, these are likely at risk too. As noted earlier,
structural MRI data are at high risk of re-identification because facial
features are available if not sufficiently removed or obscured. Since
functional MRI can also be used to single out individuals (Ravindra &
Grama, 2019) despite not having such defining features, it seems per-
tinent to extrapolate this possibility to other whole-brain imaging
techniques, for example, magneto- or electro- encephalography
(MEG-EEG). In fact, previous work has demonstrated that a simple
EEG event-related potential (ERP) from a single electrode has a dis-
criminability d-prime of around three, which is only half of standard
biometrics like finger or iris recognition (Gaspar, Rousselet, &
Pernet, 2011). Having subjects' identity at hand, whole scalp ERP clas-
sification showed a 100% accuracy in discriminating between partici-
pants (Ruiz-Blondet, Jin, & Laszlo, 2017). More recently, spectral
power derived from MEG was shown to have participant specific
embeddings dependent on sidekick cell adhesion molecule 1 encoded
by the SDK1 gene, allowing discrimination and identification even
between twins (Leppäaho et al., 2019). As technology on linking infor-
mation and singling out individuals from large data sets is evolving, we
recommend following the precautionary principle, considering any
brain-related data as personal data and consequently following the
appropriate regulations. Future work will also consider linking consent
to resources such as the Open Humans Project https://www.
openhumans.org, which enables personal data stores. Individuals are
in control of sharing their data, with whom, and for what reason. By
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aggregating individual data from different sources, such resources
increase the richness of any data for scientific analyses while preserv-
ing privacy and allowing for consented access. The Open Brain Con-
sent project provides a comprehensive starting point for resources
that account for legal sharing of data by providing consent template
forms compliant with different regulations.
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